Add BrightSurf on Google Email

Rockefeller University


Surprising origins for a rare cancer

Researchers have discovered that a rare liver cancer called fibrolamellar carcinoma is not caused by the fusion of two genes, but by the overexpression of a protein called protein kinase A. This finding has potential to reveal pathways for broad range of cancers and offer new treatment possibilities.

SourceRockefeller University·JournalCancer Research·DateJun 18, 2024

New technique sheds light on memory and learning

A new platform called TurboID has been developed to identify regulatory mechanisms driving dendritic translation, a process crucial for memory formation. The study reveals the role of micropeptides in protein synthesis and their potential link to intellectual disabilities like Fragile X syndrome.

SourceRockefeller University·JournalNature Neuroscience·DateApr 9, 2024

Universal tool for tracking cell-to-cell interactions

A new platform called uLIPSTIC enables the tracking of physical cell-to-cell interactions, allowing researchers to directly observe the elusive cellular interactome. This innovation uses a universal approach to label and quantify cell membrane interactions, opening up new avenues for understanding tissue formation and immune response.

SourceRockefeller University·JournalNature·DateMar 6, 2024

New microscopy tech answers fundamental questions

A new study using advanced microscopy technology has recorded the activity of one million neurons in mice, revealing hidden patterns of brain activity that were previously unknown. The research challenges long-held assumptions about brain dynamics and suggests that much of the brain's complexity is irrelevant background noise.

SourceRockefeller University·JournalNeuron·DateMar 6, 2024

Double trouble at chromosome ends

Scientists have discovered two new end-replication problems in DNA replication, affecting both the leading and lagging strands. This revelation changes our understanding of telomere biology and may hold clinical implications for individuals with telomere disorders, such as Coats plus syndrome.

SourceRockefeller University·JournalNature·DateFeb 28, 2024

How one of nature's most fundamental molecules forms

Scientists have made a significant breakthrough in understanding the assembly of ribosomes, the essential nanomachines that translate genetic information into proteins. A new study has provided high-resolution images of the large ribosomal subunit, revealing key steps in its formation and maturation. The findings bring researchers clos...

SourceRockefeller University·JournalScience·DateJul 6, 2023

Solving the mystery behind how nutrients enter cells

Researchers have identified FLVCR1 as a plasma membrane choline transporter in mammals, which could lead to treatments for diseases such as posterior column ataxia with retinitis pigmentosa and neurodegeneration. The discovery was made using an integrative genetic analysis approach that linked specific metabolites to transport proteins.

SourceRockefeller University·JournalCell Metabolism·DateApr 26, 2023

Illuminating the evolution of social parasite ants

Researchers at Rockefeller University have found queen-like mutants among social parasite ants, which can infiltrate and take over host colonies. These unique ants exhibit intermediate traits between worker and queen behavior, allowing them to thrive in the colony while avoiding dangers associated with leaving their nest.

SourceRockefeller University·JournalCurrent Biology·DateMar 2, 2023

The nutrient that cancer cells crave

Researchers found that arginine levels are limited in human cancers, prompting cancer cells to manipulate proteins to take up the amino acid. Starving cancer cells of arginine may lead to mutations that make them more recognizable to the immune system.

SourceRockefeller University·JournalScience Advances·DateFeb 3, 2023

How antibody therapy impacts COVID vaccines

Research finds that individuals who received monoclonal antibodies before COVID vaccination exhibit a diverse antibody response, increasing the coverage provided by vaccines. This phenomenon, known as antibody feedback inhibition, is beneficial for diversifying immune responses to viruses.

SourceRockefeller University·JournalNature·DateDec 6, 2022